Originally published here.
Managing Partner Sander Slootweg and Partner Juliette Audet discuss the role we play in the development of drugs for the rare diseases market.
This website uses cookies
Read our Privacy policy and Terms of use for more information.
Feb 1, 2023
A discussion on our contribution to rare disease drug development and innovation
Originally published here.
Managing Partner Sander Slootweg and Partner Juliette Audet discuss the role we play in the development of drugs for the rare diseases market.